AbbVie Inc. is 358.7x more valuable than MANNKIND CORP by market capitalization ($399.47 B vs $1.11 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MNKD | ABBV |
|---|---|---|
| Market cap | $1.11 B | $399.47 B |
| US-listed rank | #2559 | #28 |
| Revenue (latest FY) | $348.97M | $61.16B |
| Net income (latest FY) | $5.86M | $4.23B |
| Net margin | 1.7% | 6.9% |
| P/E (trailing FY) | 190.0 | 94.5 |
| SEC filings | 1,648 | 1,008 |
AbbVie Inc. is 358.7x more valuable than MANNKIND CORP by market capitalization ($399.47 B vs $1.11 B).
In their latest fiscal years, MANNKIND CORP reported $348.97M in revenue while AbbVie Inc. reported $61.16B.
Full pages: MANNKIND CORP and AbbVie Inc., or browse the full rankings.